Entrepreneur to make Ashya King treatment accessible in the UK

The potentially life-saving proton beam therapy that Ashya King is undergoing in the Czech Republic is “way too expensive” to be offered widely on the NHS, according to a British medical pioneer. Sanjeev Pandya, chief executive of Aim-listed Advanced Oncotherapy, said: “We are developing a new generation of smaller and significantly less expensive proton therapy machines that can fit in a hospital corridor, are modular, can be carried by three or four people and don’t require the same shielding.”

The Telegraph